加用引经药桔梗对社区获得性肺炎患者炎症指标的影响  

Effects of Jiegeng on inflammatory markers in patients with community acquired pneumonia

作　　者：张智琳[1] 梁迪思 孔祥照[1] 肖曼 Zhang Zhilin

机构地区：[1]广州市中医医院,广东广州510130 [2]广东省测试分析研究所,广东广州510070

出　　处：《中医临床研究》2019年第16期77-79,共3页Clinical Journal Of Chinese Medicine

基　　金：广东省中医药局面上科研项目(项目编号:20172115)

摘　　要：目的:对比观察莫西沙星片联用桔梗与单用莫西沙星片治疗社区获得性肺炎的疗效差异。方法:将72例社区获得性肺炎患者分为对照组和治疗组,对照组口服莫西沙星片,治疗组口服莫西沙星片和桔梗煎剂,疗程均为7天,治疗前后均抽血检查白细胞(White Blood Cell,WBC)、C反应蛋白(C-Reactive Protein,CRP)、血清粘蛋白(Seromucoid,SM)等指标,并进行咳嗽评分,比较两组各项指标的降幅是否有显著性差异。结果:治疗组SM降幅明显大于对照组(P<0.05),咳嗽评分也较对照组明显改善(P<0.05),两组的WBC和CRP降幅无显著差异(P>0.05)。结论:桔梗能增强莫西沙星片治疗社区获得性肺炎的疗效,改善患者症状。Objective: To compare the efficacy of moxifloxacin with Jiegeng (桔梗) and moxifloxacin alone on community-acquired pneumonia. Methods: 72 patients were divided into the control group and treatment group. The control group received oral moxifloxacin tablets. The treatment group received oral moxifloxacin tablets and Jiegeng. The course of treatment was 7 days. Results: The SM reduction in the treatment group was significantly greater than that in the control group(P<0.05), and the cough score was significantly improved(P<0.05). There was no significant difference in WBC and CRP between the two groups(P>0.05). Conclusion: Jiegeng can enhance the efficacy of moxifloxacin tablets on community-acquired pneumonia, by improving the symptoms of patients.

关 键 词：社区获得性肺炎 桔梗 莫西沙星片 炎症指标 

分 类 号：R563.1[医药卫生—呼吸系统]